发明名称 GENE THERAPY FOR SPINAL CORD DISORDERS
摘要 This disclosure provides methods and compositions for treating disorders or injuries that affect motor function and control in a subject. In one aspect, the invention provides a method to deliver a transgene to a subject's spinal cord by administering a recombinant neurotropic viral vector containing the transgene. The viral vector delivers the transgene to a region of the deep cerebellar nuclei region of the brain. Also provided are compositions and methods to deliver a transgene to a subject's spinal cord by administering a recombinant neurotropic viral vector containing the transgene to the motor cortex region of the subject's brain.
申请公布号 US2009069261(A1) 申请公布日期 2009.03.12
申请号 US20070934148 申请日期 2007.11.02
申请人 GENZYME CORPORATION 发明人 DODGE JAMES;SHIHABUDDIN LAMYA;PASSINI MARCO;CHENG SENG H.;O'RIORDAN CATHERINE
分类号 A61K48/00;A61P25/00 主分类号 A61K48/00
代理机构 代理人
主权项
地址